| 1 |
32428800 | Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification. | 2020 Jul |
1 |
| 2 |
30630536 | EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma. | 2019 Jan 10 |
3 |
| 3 |
30675212 | Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression. | 2019 Feb |
1 |
| 4 |
26311121 | Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma. | 2016 Feb 1 |
1 |
| 5 |
22907805 | Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer. | 2013 Aug |
3 |
| 6 |
22977493 | Prognostic value of co-expression of STAT3, mTOR and EGFR in gastric cancer. | 2011 Mar |
2 |
| 7 |
21102259 | Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer. | 2010 Dec |
2 |
| 8 |
18474878 | EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. | 2008 Jul 1 |
2 |
| 9 |
15890569 | Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. | 2005 Jun 1 |
3 |